149 related articles for article (PubMed ID: 23777975)
1. Microvascular dysfunction is associated with plasma osteoprotegerin levels in patients with acute myocardial infarction.
Løgstrup BB; Høfsten DE; Christophersen TB; Møller JE; Bjerre M; Flyvbjerg A; Bøtker HE; Egstrup K
Coron Artery Dis; 2013 Sep; 24(6):487-92. PubMed ID: 23777975
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive coronary flow reserve is correlated with microvascular integrity and myocardial viability after primary angioplasty in acute myocardial infarction.
Montisci R; Chen L; Ruscazio M; Colonna P; Cadeddu C; Caiati C; Montisci M; Meloni L; Iliceto S
Heart; 2006 Aug; 92(8):1113-8. PubMed ID: 16449513
[TBL] [Abstract][Full Text] [Related]
3. Correlation between left ventricular global and regional longitudinal systolic strain and impaired microcirculation in patients with acute myocardial infarction.
Løgstrup BB; Høfsten DE; Christophersen TB; Møller JE; Bøtker HE; Pellikka PA; Egstrup K
Echocardiography; 2012 Nov; 29(10):1181-90. PubMed ID: 22862151
[TBL] [Abstract][Full Text] [Related]
4. Impact of coronary microvascular function on long-term cardiac mortality in patients with acute ST-segment-elevation myocardial infarction.
van de Hoef TP; Bax M; Meuwissen M; Damman P; Delewi R; de Winter RJ; Koch KT; Schotborgh C; Henriques JP; Tijssen JG; Piek JJ
Circ Cardiovasc Interv; 2013 Jun; 6(3):207-15. PubMed ID: 23735476
[TBL] [Abstract][Full Text] [Related]
5. Impaired coronary microvascular and left ventricular diastolic function in patients with inflammatory bowel disease.
Caliskan Z; Gokturk HS; Caliskan M; Gullu H; Ciftci O; Ozgur GT; Guven A; Selcuk H
Microvasc Res; 2015 Jan; 97():25-30. PubMed ID: 25128749
[TBL] [Abstract][Full Text] [Related]
6. Coronary microvascular function is independently associated with left ventricular filling pressure in patients with type 2 diabetes mellitus.
Kawata T; Daimon M; Miyazaki S; Ichikawa R; Maruyama M; Chiang SJ; Ito C; Sato F; Watada H; Daida H
Cardiovasc Diabetol; 2015 Aug; 14():98. PubMed ID: 26242308
[TBL] [Abstract][Full Text] [Related]
7. Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction.
Erkol A; Oduncu V; Pala S; Kızılırmak F; Kılıcgedik A; Yılmaz F; Güler A; Karabay CY; Kırma C
Atherosclerosis; 2012 Mar; 221(1):254-9. PubMed ID: 22265272
[TBL] [Abstract][Full Text] [Related]
8. Osteoprotegerin is independently associated with metabolic syndrome and microvascular complications in type 2 diabetes mellitus.
Tavintharan S; Pek LT; Liu JJ; Ng XW; Yeoh LY; Su Chi L; Chee Fang S
Diab Vasc Dis Res; 2014 Sep; 11(5):359-62. PubMed ID: 25005034
[TBL] [Abstract][Full Text] [Related]
9. Influence of abnormal glucose metabolism on coronary microvascular function after a recent myocardial infarction.
Løgstrup BB; Høfsten DE; Christophersen TB; Møller JE; Bøtker HE; Pellikka PA; Egstrup K
JACC Cardiovasc Imaging; 2009 Oct; 2(10):1159-66. PubMed ID: 19833304
[TBL] [Abstract][Full Text] [Related]
10. Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Pedersen S; Mogelvang R; Bjerre M; Frystyk J; Flyvbjerg A; Galatius S; Sørensen TB; Iversen A; Hvelplund A; Jensen JS
Cardiology; 2012; 123(1):31-8. PubMed ID: 22964478
[TBL] [Abstract][Full Text] [Related]
11. Osteoprotegerin levels change during STEMI and reflect cardiac function.
Lindberg S; Jensen JS; Hoffmann S; Iversen AZ; Pedersen SH; Mogelvang R; Galatius S; Flyvbjerg A; Bjerre M
Can J Cardiol; 2014 Dec; 30(12):1523-8. PubMed ID: 25475457
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction.
Crisafulli A; Micari A; Altavilla D; Saporito F; Sardella A; Passaniti M; Raffa S; D'anneo G; Lucà F; Mioni C; Arrigo F; Squadrito F
Clin Sci (Lond); 2005 Oct; 109(4):389-95. PubMed ID: 15926884
[TBL] [Abstract][Full Text] [Related]
13. Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease.
Tona F; Serra R; Di Ascenzo L; Osto E; Scarda A; Fabris R; Montisci R; Famoso G; Tellatin S; Foletto M; Giovagnoni A; Iliceto S; Vettor R
Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):447-53. PubMed ID: 24548662
[TBL] [Abstract][Full Text] [Related]
14. Association between coronary flow reserve, left ventricular systolic function, and myocardial viability in acute myocardial infarction.
Løgstrup BB; Høfsten DE; Christophersen TB; Møller JE; Bøtker HE; Pellikka PA; Egstrup K
Eur J Echocardiogr; 2010 Sep; 11(8):665-70. PubMed ID: 20308193
[TBL] [Abstract][Full Text] [Related]
15. Relation of circulating osteoprotegerin levels on admission to microvascular obstruction after primary percutaneous coronary intervention.
Erkol A; Pala S; Kırma C; Oduncu V; Dündar C; Izgi A; Tigen K; Gibson CM
Am J Cardiol; 2011 Mar; 107(6):857-62. PubMed ID: 21247537
[TBL] [Abstract][Full Text] [Related]
16. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial.
Fuernau G; Poenisch C; Eitel I; de Waha S; Desch S; Schuler G; Adams V; Werdan K; Zeymer U; Thiele H
Eur J Heart Fail; 2014 Aug; 16(8):880-7. PubMed ID: 24903195
[TBL] [Abstract][Full Text] [Related]
17. Impaired coronary flow reserve in young patients affected by severe psoriasis.
Osto E; Piaserico S; Maddalozzo A; Forchetti G; Montisci R; Famoso G; Giovagnoni A; Peserico A; Iliceto S; Tona F
Atherosclerosis; 2012 Mar; 221(1):113-7. PubMed ID: 22236480
[TBL] [Abstract][Full Text] [Related]
18. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction.
Çanga A; Durakoğlugil ME; Erdoğan T; Kirbaş A; Yilmaz A; Çiçek Y; Ergül E; Çetin M; Kocaman SA
J Cardiol; 2012 Nov; 60(5):355-60. PubMed ID: 22727437
[TBL] [Abstract][Full Text] [Related]
20. Association between discharge heart rate and left ventricular adverse remodelling in ST segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
Joyce E; Hoogslag GE; Leong DP; Fox K; Schalij MJ; Marsan NA; Bax JJ; Delgado V
Heart; 2013 Apr; 99(8):556-61. PubMed ID: 23468514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
